Who
Christine Ann Fox
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Mereo BioPharma Group.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $269K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Jan 2024
- Last trade
- 1 Feb 2026
- Last filed
- 2 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Feb 2026filed 2 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —315,750 at $0.00 | filing |
| 1 Feb 2026filed 2 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —105,250 at $0.00 | filing |
| 1 Feb 2026filed 2 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —280,000 at $0.00 | filing |
| 1 Feb 2026filed 2 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —315,750 at $0.00 | filing |
| 1 Feb 2026filed 2 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —105,250 at $0.00 | filing |
| 1 Feb 2026filed 2 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —280,000 at $0.00 | filing |
| 25 Jan 2025filed 28 Jan 2025 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —262,000 at $0.00 | filing |
| 13 Sep 2024filed 16 Sep 2024 | MREO Mereo BioPharma GroupBiotechnology | SEC FORM 4 Sold | $81K19,158 at $4.22 | filing |
| 12 Sep 2024filed 16 Sep 2024 | MREO Mereo BioPharma GroupBiotechnology | SEC FORM 4 Sold | $41K9,128 at $4.47 | filing |
| 11 Sep 2024filed 13 Sep 2024 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code M | —60,000 at $0.00 | filing |
| 11 Sep 2024filed 13 Sep 2024 | MREO Mereo BioPharma GroupBiotechnology | SEC FORM 4 Code M | —60,000 at $0.00 | filing |
| 26 Jun 2024filed 27 Jun 2024 | MREO Mereo BioPharma GroupBiotechnology | SEC FORM 4 Sold | $100K29,439 at $3.39 | filing |
| 25 Jun 2024filed 27 Jun 2024 | MREO Mereo BioPharma GroupBiotechnology | SEC FORM 4 Sold | $48K12,990 at $3.69 | filing |
| 21 Jun 2024filed 25 Jun 2024 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code M | —90,000 at $0.00 | filing |
| 21 Jun 2024filed 25 Jun 2024 | MREO Mereo BioPharma GroupBiotechnology | SEC FORM 4 Code M | —90,000 at $0.00 | filing |
| 25 Jan 2024filed 26 Jan 2024 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —245,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.